The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? (Q38166991)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Steven B Abramson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

5

object named as

T Spector

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Anne C Bay-Jensen

2

object named as

A C Bay-Jensen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

M A Karsdal

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

P Pastoureau

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Christiansen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K Henriksen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S R Goldring

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

V Kraus

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

0 references

publication date

27 November 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

73

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

336-348

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Prospects for disease modification in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis: an update with relevance for clinical practice

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis: Is it a disease of cartilage or of bone?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Subchondral bone as a key target for osteoarthritis treatment.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Genetic factors in OA pathogenesis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Mechanical loading, estrogen deficiency, and the coupling of bone formation to bone resorption

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Structure-modifying agents for osteoarthritis: an update

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Estrogens, cartilage, and osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Body mass index in young men and the risk of subsequent knee and hip osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Strategies for the prevention and management of osteoarthritis of the hip and knee

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis severity is sex dependent in a surgical mouse model

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM).

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Increased metabolism of bone collagen in post-menopausal female osteoporotic femoral heads

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Obesity and osteoarthritis of the knee: evidence from the National Health and Nutrition Examination Survey (NHANES I).

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis protects against femoral neck fracture: the MEDOS study experience

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Risk factors for progression of lumbar spine disc degeneration: the Chingford Study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Bone mineral density and knee osteoarthritis in elderly men and women. the framingham study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The role of bone metabolism in osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Is osteoarthritis a systemic disorder of bone?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Evidence for altered synthesis of type II collagen in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Scintigraphic assessment of osteoarthritis of the knee joint

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Subchondral bone should be the main target for the treatment of pain and disease progression in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis: epidemiology

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Trabecular morphometry by fractal signature analysis is a novel marker of osteoarthritis progression

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Quantitative bone marrow lesion size in osteoarthritic knees correlates with cartilage damage and predicts longitudinal cartilage loss

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The association of bone marrow lesions with pain in knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Abnormal cancellous bone collagen metabolism in osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Evidence of early subchondral bone changes in the meniscectomized guinea pig. A densitometric study using dual-energy X-ray absorptiometry subregional analysis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Fundamental subchondral bone changes in spontaneous knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Alterations in periarticular bone and cross talk between subchondral bone and articular cartilage in osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Bone and cartilage in osteoarthritis: is what's best for one good or bad for the other?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Are nonresorbing osteoclasts sources of bone anabolic activity?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Hyaluronic acid reverses the abnormal synthetic activity of human osteoarthritic subchondral bone osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Subchondral bone and osteoarthritis: biological and cellular aspects

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Regulation of subchondral bone osteoblast metabolism by cyclic compression

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1beta and oncostatin M pre-treated non-sclerotic osteoblasts.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Direct assessment of articular cartilage and underlying subchondral bone reveals a progressive gene expression change in human osteoarthritic knees

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Evidence for the dysregulated expression of TWIST1, TGFβ1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Phenotypic characterization of osteoarthritic osteocytes from the sclerotic zones: a possible pathological role in subchondral bone sclerosis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis cartilage histopathology: grading and staging.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Mechanisms of Disease: the link between RANKL and arthritic bone disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Analysis of the kinetics of osteoclastogenesis in arthritic rats

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Should subchondral bone turnover be targeted when treating osteoarthritis?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

How proteases regulate bone morphogenesis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strength

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoclast activity and subtypes as a function of physiology and pathology--implications for future treatments of osteoporosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Prognostic biomarkers in osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and rantes production by arthritic osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Alendronate protects against articular cartilage erosion by inhibiting subchondral bone loss in ovariectomized rats.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Efficacy of zoledronic acid in treatment of teoarthritis is dependent on the disease progression stage in rat medial meniscal tear model

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effects of risedronate on osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthri

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Identification of the calcitonin receptor in osteoarthritic chondrocytes

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Positive Regulation of Endochondral Cartilage Growth by Perichondrial and Periosteal Calcitonin

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effect of calcitonin on glycosaminoglycan synthesis by embryo calf bone cells in vitro.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Calcitonin delays the progress of early-stage mechanically induced osteoarthritis. In vivo, prospective study.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Influence of food intake on the bioavailability and efficacy of oral calcitonin

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Inhibition of cathepsin K for treatment of osteoporosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Cathepsin K inhibition reduces CTXII levels and joint pain in the guinea pig model of spontaneous osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Down-regulation of cathepsin K in synovium leads to progression of osteoarthritis in rabbits.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Endogenous sex steroid levels in women with generalised osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Estradiol and its metabolites and their association with knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The incidence and natural history of knee osteoarthritis in the elderly, the framingham osteoarthritis study

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The effects of estrogen on osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

A microarray analysis of full depth knee cartilage of ovariectomized rats

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Estradiol protects cultured articular chondrocytes from oxygen-radical-induced damage

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Immunohistochemical detection of estrogen receptor alpha in articular chondrocytes from cows, pigs and humans: in situ and in vitro results

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Pharmacology of arthralgia with estrogen deprivation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Clinical effects of strontium ranelate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effects of strontium ranelate on spinal osteoarthritis progression.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Strontium ranelate increases cartilage matrix formation

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The role of bone in the treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Early radiographic features in patients with anterior cruciate ligament rupture

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Modification of articular cartilage and subchondral bone pathology in an ovine meniscectomy model of osteoarthritis by avocado and soya unsaponifiables (ASU).

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Subchondral bone changes in hand and knee osteoarthritis detected by radiography

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

PTHrP promotes chondrogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Developmental regulation of the growth plate

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Parathyroid hormone-related protein regulates proliferation of condylar hypertrophic chondrocytes.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Volumetric bone mineral density of the tibia is not increased in subjects with radiographic knee osteoarthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Fracture risk before and after total hip replacement in patients with osteoarthritis: Potential benefits of bisphosphonate use

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

The predictive role of scintigraphy in radiographic osteoarthritis of the hand

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204111

21 January 2018

Identifiers

10.1136/ANNRHEUMDIS-2013-204111

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24285494%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38166991&oldid=1978956036"